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Abstract
Background: Despite the introduction of Human papillomavirus (HPV) vaccination in national immunization
programs (NIPs), vaccination rates in most countries remain relatively low. An understanding of the reasons
underlying decisions about whether to vaccinate is essential in order to promote wider spread of HPV vaccination.
This is particularly important in relation to policies seeking to address shortfalls in current HPV campaigns. The aim
of this study was to explore prevailing perspectives concerning HPV vaccination among girls, boys, and parents,
and so to identify potential determinants of HPV vaccination decisions in these groups.
Method: Perspectives were explored using Q-methodology. Forty-seven girls, 39 boys, and 107 parents in the
Netherlands were asked to rank a comprehensive set of 35 statements, assembled based on the health belief
model (HBM), according to their agreement with them. By-person factor analysis was used to identify common
patterns in these rankings, which were interpreted as perspectives on HPV vaccination. These perspectives were
further interpreted and described using data collected with interviews and open-ended questions.
Results: The analysis revealed four perspectives: “prevention is better than cure,” “fear of unknown side effects,”
“lack of information and awareness,” and “my body, my choice.” The first two perspectives and corresponding
determinants of HPV vaccination decisions were coherent and distinct; the third and fourth perspectives were
more ambiguous and, to some extent, incoherent, involving doubt and lack of awareness and information
(perspective 3), and overconfidence (perspective 4).
Conclusions: Given the aim of publically funded vaccination programs to minimize the spread of HPV infection
and HPV-related disease and the concerns about current uptake levels, our results indicate that focus should be
placed on increasing awareness and knowledge, in particular among those in a modifiable phase.
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Background
Human papillomavirus (HPV) is a common sexually
transmitted disease in men and women. Most sexually
active women and men become infected at some point
in their lives, and infections may also reoccur [1]. Des-
pite the transient nature of HPV, persistent infection
with oncogenic HPV strains may cause cancer. Virtually
99% of cervical cancers in women are caused by genital
HPV infection [2]. Worldwide, cervical cancer is the sec-
ond most common cancer among women, resulting in
270,000 deaths annually [1]. Although cervical cancer
has received much attention, oncogenic HPV strains also
affect men [3, 4]. An estimated 90% of anal cancers, 60%
of penile cancers, and 70% of oropharyngeal cancers are
linked directly to oncogenic HPV strains [5]. In devel-
oped countries, the number of HPV-related (penile,
oral, and anal) cancers in men has been estimated to
be similar to that of cervical cancers in women [4],
creating a high disease burden [3, 6].
In 2006, the European Medicines Agency and the US
Federal Drug Administration approved the first vaccines
against HPV. Because these were the first vaccines aimed
at preventing cancer, wide policy debate about whether
they should be included in national immunization pro-
grams (NIPs) ensued. The Netherlands, where the current
study was conducted, was among the first countries to in-
clude the vaccine in its NIP, in 2008. However, this was
only for girls and not for boys, which is currently still the
case. Some countries that introduced the vaccine to their
NIPs later also included HPV immunization for boys [7].
Despite the introduction of HPV vaccination in NIPs,
vaccination rates in most countries remain relatively
low. Countries that engage in school-based vaccination
programs generally have significantly higher uptakes
than do those that offer the vaccine in alternative
schemes, and uptake is generally lower among boys than
among girls in countries recommending immunization for
both sexes [8].
As the rationale behind publically funded vaccination
is to achieve high coverage and, thereby, herd immun-
ity, understanding the reasons underlying the decisions
of children and their parents about whether to vaccin-
ate is important to achieve greater permeation of the
practice. Such understanding is particularly important
for policies aiming to address shortfalls in current HPV
campaigns. Furthermore, the novelty of HPV vaccin-
ation, as the first immunization measure aimed at pre-
venting cancer, serves as an interesting case providing
insight into how this “new generation” of vaccines is
valued among designated users. Therefore, the aims of
this study were to explore prevailing perspectives on
HPV vaccination among girls, boys, and parents, and to
identify underlying determinants shaping decisions
about whether to vaccinate against HPV.
Determinants of vaccination against HPV
Much attention has been devoted to determinants in-
fluencing HPV vaccine uptake. Most studies have found
that the perceived benefits of the vaccine have consider-
able effects on decisions about whether to vaccinate;
the intention to vaccinate increases with the perceived
benefits. Commonly reported benefits involve the per-
ceived effectiveness of the vaccine [9–11] and beliefs
that the vaccine will protect against or minimize the
severity of HPV-related disease and/or promote the
future health of recipients and their future partners and
others in the community through herd immunity [9, 10,
12–14].
Perceived barriers also influence decisions about
whether to vaccinate against HPV. Reported barriers
entail the low perceived effectiveness of the vaccine,
concerns about side effects and safety, fear of needles,
fear of sexual disinhibition or promiscuity stigma, and
lack of knowledge and awareness [9, 10, 14–18]. The
latter involve misconceptions regarding the physical
injection site [12] and the prophylactic effect of the
vaccine [12, 19]. In addition, there is low awareness of
the existence of HPV vaccination for men, as the vac-
cine has been advertised mainly for women. Thus, men
have not adopted HPV immunization as a norm [20],
potentially emasculating those who decide to be vacci-
nated [17]. Other barriers, such as lack of trust in the
government (promoting the vaccine) and/or concerns
about commercial interests of pharmaceutical compan-
ies, have also been reported to compromise HPV vac-
cine uptake [9, 10, 14, 15].
Another important determinant affecting decisions
about whether to vaccinate is the perceived severity
of HPV and perceived susceptibility to HPV-related
diseases; most studies have shown that beliefs about
the severity and likelihood of HPV infection and/or
development of HPV-related diseases positively affect
vaccination uptake [13–15, 20–22]. However, many
girls perceive a low likelihood of contracting HPV,
perhaps due to the young vaccination age [9, 10].
Studies have also suggested that anticipated regret of
(in)action plays an important role in HPV vaccin-
ation decisions [12, 13, 23, 24]. Furthermore, general
acceptance of other childhood vaccinations and pro-
fessional endorsement have been shown to affect
HPV vaccine acceptance [14, 15, 17, 25].
In addition to all of these beliefs, demographic deter-
minants (e.g., education, religion), social influences, and
subjective norms (e.g., peer acceptance) have been found
to affect the decision to vaccinate [10, 21, 25–27].
Finally, demographic characteristics such as education
level have been reported to have less influence than
the above-mentioned belief factors on vaccination ac-
ceptance [21, 28].
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Methods
This study was conducted using Q-methodology, an
approach designed to explore subjective perspectives
[29, 30]. Study participants were presented with a sam-
ple of opinion statements about HPV vaccination and
instructed to rank them according to their agreement
with them, thus revealing their subjective viewpoint
[29, 30]. Qualitative material was collected by asking
participants to explain their statement rankings and an-
swer follow-up questions. Through by-person factor ana-
lysis, significant clusters of correlations among rankings
were identified. The assumption underlying this analysis
was that participants who ranked the statements similarly
had similar perspectives on HPV vaccination. For each
factor, a composite ranking of the statements was com-
puted, which was the basis for interpretation and descrip-
tion of the factor as perspective on HPV vaccination. As
the aim of Q-methodology is to explore the variety of
viewpoints that people hold, not to make claims about
people expressing them [30], participants were gathered
purposively to ensure diversity.
Statement set development
To develop a comprehensive and structured set of state-
ments, including all beliefs and motives potentially affect-
ing decisions to vaccinate against HPV, we used the health
belief model (HBM) as the theoretical framework for this
study. The HBM can help to explain and predict health
behaviours [31]. It has proven relevance in various fields
of preventive care, including HPV vaccination behaviour
[32, 33]. Hence, we used HBM as reference for selecting a
set of statements covering the variety of beliefs and
motives relevant to our study. The HBM has five major
components shaping individuals’ health beliefs: perceived
severity (seriousness of a disease), perceived susceptibility
(likelihood of getting a disease), perceived barriers (tan-
gible and psychological costs of the action), perceived ben-
efits (advantages gained from the action), and self-efficacy
(belief in one’s ability to execute a behaviour) [35]. Per-
ceived severity and susceptibility have been described as
“perceived threat,” which provides the strength and power
to act, whereas assessment of the potential benefits and
barriers defines the preferred path of action [34]. To accept
or follow a preventive action, optimal beliefs about suscep-
tibility and severity are sufficient only when the perceived
benefits outweigh the perceived barriers, reducing the per-
ceived threat [34, 35]. Self-efficacy also affects individuals’
health beliefs [34]. In addition to these five major compo-
nents, an action is further influenced by internal and exter-
nal “cues to action” (e.g., symptoms, media) and “modifying
factors” (e.g., age, education, ethnicity) (34). We added a
“social influences” component, involving subjective norms
(e.g., beliefs about whether significant others think that one
should engage in a behaviour) to the model, based on find-
ings that the social environment and subjective norms (e.g.,
peer acceptance) are important influences on HPV vaccin-
ation decisions [10, 21, 25–27]. Although some researchers
consider this factor to be part of the “cues to action” com-
ponent, others have used it as an additional component in
an extended HBM [36, 37]. Figure 1 depicts the adapted
version of the HBM used in this study, which is based on
Champion and Skinner [34].
Through a non-systematic review of scientific, empir-
ical, and popular literature, two researchers (NP, JC)
Fig. 1 Health Belief Model
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independently identified a large variety of motives and
beliefs potentially influencing decisions to vaccinate
against HPV among girls, boys, and parents. The scien-
tific literature was searched using PubMed. In addition,
interviews were conducted with two experts in the field
of HPV vaccination from two academic medical centres
in the Netherlands (one specializing in obstetrics and
gynaecology and the other in obstetrics, gynaecology,
immunology, and oncology). The two researchers divided
the identified motives and beliefs according to the compo-
nents of the extended HBM, and then reviewed the litera-
ture a second time to ensure that nothing had been
overlooked.
Four researchers (NP, HD, JE, JC) developed an initial
set of 48 statements, and the two experts were asked to
evaluate its exhaustiveness. Following their feedback,
minor adjustments were made; some statements were
merged or deleted because they covered similar topics,
and the wording of several statements was revised. There-
after, two additional HPV policy experts (IW, RB) pro-
vided feedback on the statement set, leading to further
reduction of the number of statements and additional ad-
justments to language use. This iterative process resulted
in a draft set of 35 statements.
To ensure the applicability and comprehensibility of
the statement set, a pilot study involving four parents
and six children was conducted. Based on its results,
one statement concerning sexual disinhibition (“Vaccin-
ation makes you feel protected against HPV, but that is
false”) was removed, as it was considered to be outdated.
This statement was replaced with statement 11, regard-
ing anticipated regret of inaction, which the pilot study
revealed was a missing component. In addition, minor
adjustments were made to suit children’s linguistic abil-
ities. The final statement set, categorized according to
HBM components, is presented in Table 1.
Data collection
An external agency recruited participants purposively to
achieve demographic and cultural diversity in terms of
age, gender, education level, religion, and ethnicity. In
addition, the following inclusion criteria were applied:
girls and boys aged 10–16 years who had not yet re-
ceived HPV vaccination, and parents or legal guardians
of such children. Participating parents and children did
not have to be from the same families. Initially, three
sessions were planned in each of three locations in the
Netherlands (Amsterdam, Amersfoort, and Rotterdam).
Because 16 participants did not show up, an additional
session was organized in Rotterdam. Each session was
attended by 6–15 participants. All respondents received
€25 gift cards and reimbursement for travel expenses.
Each session (moderators: NP, HD) was organized in the
following manner: parents and children were separated
into different rooms and received a short introduction
on HPV (Appendix 1), which provided limited informa-
tion to minimize potential influence. Participants re-
ceived written instructions for the exercise. Because
these instructions appeared to be too difficult for
children in the first session, we switched to verbal in-
structions for all sessions with children. Thereafter,
each respondent was presented with the 35 statements
printed on cards, in random order, and asked to care-
fully read all cards and sort them into three piles repre-
senting statements they agreed with, disagreed with,
and found to be neutral or irrelevant. The participants
were then instructed to reread the cards in each pile,
prior to ranking them on the score sheet (Fig. 2). Re-
spondents first placed statements with which they
agreed on the right side of the score sheet. They placed
the two statements with which they agreed most in the
two spots in the far right column, followed by the three
remaining statements with which they agreed most,
and so on. In the same manner, respondents ranked
statements with which they disagreed and those that
they found to be neutral on the left side and in the
centre of the score sheet, respectively.
After ranking the statements, each participant was
asked three open-ended questions. They were asked to
elaborate on their choices of the two statements with
which they most agreed and disagreed, and to briefly de-
scribe their opinion about HPV vaccination. Finally, par-
ticipants were asked to fill in a questionnaire, which
included questions regarding demographic characteris-
tics, knowledge about HPV, HPV vaccination, and their
intended vaccination decision.
After data analysis, interviews were conducted with
eight participants showing the highest correlations with
the identified perspectives (i.e., two participants per per-
spective). These ex-post interviews were transcribed
verbatim.
Analysis
Individual statement rankings were subject to by-person
factor analysis (i.e., centroid factor extraction, followed
by varimax rotation) using PQMethod 2.11 [38]. Identi-
fied factors were interpreted as perspectives on HPV
vaccination using the composite statement rankings.
Consensus statements (i.e., those whose rankings did not
differ significantly between any pair of factors) and dis-
tinguishing statements (i.e., those whose rankings in one
factor differed significantly from those in all other fac-
tors) were identified. Next, the interpretation and de-
scription of each factor was supplemented with the
answers to the open-ended questions from participants
whose rankings were associated with that perspective
(p < .05). Finally, ex-post interview data were used to
verify and/or clarify interpretations of the factors. Two
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Table 1 Idealized ranking of the 35 statements
Statement Perspective
I II III IV
Self-efficacy
1 You yourself can do something about your health by getting vaccinated against HPV +3** -2 +1** −1
Cues to action
2 I find advice from my GP about HPV vaccination important +2 0** +3* +3
3 Good information can be found about the benefits and drawbacks of HPV vaccination +1 −2** −1** +2
4 Information about HPV vaccination often only deals with the benefits or only with the
drawbacks
0 +2 0 +1
5 I am well familiar with HPV and the diseases you can get as a consequence of HPV 0 −1** −3** 0
6 It is clear to me what HPV vaccination protects against +1 +1 −4** +1
7 My decision to get vaccinated depends on the experiences of other people I know −1** 0 −1 −1
8 I talk with others about the benefits and drawbacks of getting vaccinated against HPV 0 +2** −2** 0
9 If you can prevent diseases by getting vaccinated, this is a good idea +4* +1 +4* +2
10 I worry about the side effects of HPV vaccination on the long term 0 +4** +1 0
11 If you don’t get vaccinated and get a disease as a consequence of HPV, you will regret +2 0 +2 0
12 If you get vaccinated against HPV and get serious side effects, you will regret 0** +3** +1 +2
Perceived susceptibility
13 I worry about the diseases you can get if you get infected with HPV +1* −1** +1* −2**
14 The chance of HPV infection seems small to me −1** +1 0* +1
15 I don't see vaccination against HPV as important −4** −1 −2** −2
16 Vaccination against HPV is only important when you become sexually active −2 −2 −1 −3**
Perceived severity
17 HPV is not important enough to get vaccinated against −3** −1** −2 −2
18 The diseases you can get due to HPV infection are serious +3** +2 0** +3
Perceived benefits
19 HPV infection is a bigger problem for girls than it is for boys 0 0 0 −1
20 Getting vaccinated against HPV has more drawbacks than benefits −1** +1* 0** 0*
21 Getting vaccinated is something you do to protect both yourself and others against
infection and diseases as a consequence of HPV
+4** +1** +3** +2**
22 Because you can infect each other with HPV both girls and boys must get themselves
vaccinated
+2 0 +2 0
Perceived barriers
23 I am against vaccination in general −4 −3 −3 −3
24 Deciding to get vaccinated or not is difficult for children +2** +3 +2 +1**
25 I have enough information to decide on vaccination yes or no 0** −1** −4** +3**
26 Fear of the needle stick plays a role in the choice of getting vaccinated against HPV −2** −4** −1 −1
27 The possible side effects of HPV vaccination on the long term are not clear to me +1** +4** +4** 0**
28 I find advice from the government about vaccination against HPV important +3** 0* +2** −2**
29 The companies that produce HPV vaccines try to persuade you to get yourself vaccinated −1 +3** 0 +1**
30 The choice of getting yourself vaccinated against HPV should be made by the parent(s)
and child together
+1** +2** +3** +4**
31 A child should decide for herself or himself on getting vaccinated against HPV −3** −2** 0** +4**
32 I find HPV vaccination a tricky topic because it has to do with sexual activity −2** −3 −1** −3
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respondents with the highest factor loadings (i.e. correla-
tions between the respondent and the factors) were
selected per factor for the ex-post interviews, as those
respondents can be seen as holding the most similar
perspective to the one represented by the factor. Two
respondents per factor was considered sufficient to verify
and clarify interpretations, as no new themes emerged
after these interviews.
Results
The sample consisted of 193 participants [47 (24.4%)
girls, 39 (20.2%) boys, 107 parents (55%; 46.1% mothers,
9.3% fathers)]. The average age was 45 (range 29–59)
years among parents, and 13 (range 10–16) years among
children. Forty-seven parents and children were from
the same families (48.7% of the total sample). Four chil-
dren were excluded from the study because a) they did
not complete the exercise, b) understand the instruc-
tions after repeated explanation, or c) understand the
majority of statements.
Inspection of the solutions supported by the data
yielded a four-factor solution. These factors were suffi-
ciently distinct and clearly interpretable, and explained
50% of the variance. Table 1 shows the composite rank-
ing of statements for each perspective.
Perspective 1: “Prevention is better than cure”
This pro-vaccination perspective, with which 45 partici-
pants [35 (78%) parents, 1 (2%) girl, 9 (20%) boys] were
associated significantly, emphasized the perceived
threat of HPV and HPV-related diseases. An urgency to
take preventive measures against HPV prevailed, as
reflected in the rankings of statements describing the
perceived severity of and susceptibility to HPV and
HPV-related diseases. Participants with this perspective
believed that they were likely to be exposed to HPV in-
fection (statement 14 was ranked −1), were concerned
about its potential consequences to their health
(st.13,+1; st.18,+3), and placed importance on preven-
tion through vaccination (st.17,-3).
From this perspective, the benefits of HPV vaccin-
ation clearly outweighed potential barriers. Vaccination
was considered to be a positive means of preventive
care to protect oneself and others (st.21,+4), with more
advantages than disadvantages (st.20,-1), giving people
the direct ability to influence their health (st.1,+3).
Taking preventive measures was seen as a small sacrifice
relative to the potential consequences of HPV-related dis-
eases, as highlighted in several answers to open-ended
questions with the recurring idiom of “prevention is better
than cure.”
Fig. 2 Score Sheet
Table 1 Idealized ranking of the 35 statements (Continued)
Statement Perspective
I II III IV
Social influences
33 I would like to know the opinion of others in my close circle (family, friends or classmates)
before I decide on getting vaccinated
−1** 0 +1** −3
34 My decision about HPV vaccination is influenced by my religion or culture −3 −3 −3 −4**
35 If you get yourself vaccinated against HPV others will think that you are sexually active −2* −4 −2* −4
*p < .05, **p < 0.01 vs. all other factors
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Another theme that emerged within this viewpoint
was the perceived complexity of HPV and HPV-related
diseases, reflected in beliefs about who should make the
vaccination decision [i.e., not children alone (st.31,-3) or
parents and children together (st.30,+1)]. Parents stated
that they would rather announce this decision to their
children than negotiate it with them. They felt strongly
that children receiving formal invitation letters for local
vaccination sessions could not understand such complex
information and were incapable of making informed
decisions.
Given the perceived complexity of the topic, partici-
pants with this perspective valued professional advice
from trusted sources, such as governmental recommen-
dations (st.28,+3). This perception may explain the
minimal value placed on social influences (st.33,-1;
st.34,-3; st.8,0): one mother said, “I do not rely on the
opinion of my neighbor or sister-in-law; I collect good
information from the Internet about pros and cons and
then make my choice.” These participants’ trusting rela-
tionships with the government may additionally explain
their generally favorable opinion of HPV vaccination. In
ex-post interviews, respondents opined that the govern-
ment would not add a vaccine to the NIP without proper
and relevant justification. In the context of healthcare and
the “medical world” in the Netherlands, participants with
this perspective trusted the government to make good,
wise choices with people’s best interests in mind.
Perspective 2: “Fear of unknown side effects”
This perspective, with which 46 participants [40 (87%)
parents, 4 (9%) girls, 2 (4%) boys] were associated sig-
nificantly, did not involve the strength and force to take
action against HPV through vaccination, as the per-
ceived severity and susceptibility of HPV-related disease
was minimal. The perceived likelihood of exposure to
HPV-related disease was minimal (st.14,+1) and concern
about contracting HPV-related disease was negligible
(st.13,-1). Hence, respondents with this perspective did
not perceive HPV to be sufficiently important to warrant
vaccination (st.17,-1).
Perceived barriers, particularly fear about the poten-
tial unknown long-term side effects of HPV vaccin-
ation (st.10,+4; st.27,-4), dominated this perspective.
In this way, HPV vaccination was distinct from other
childhood vaccinations (st.23,-3). One mother stated,
“[I have] concerns about the side effects in the long
term. The vaccine was developed only recently. The
possible long-term side effects cannot be known yet.”
Respondents also referred to the effectiveness of the
vaccine, emphasizing that the current vaccine does not
protect against all cancer-causing HPV strains. One
interviewee also questioned the duration of the vac-
cine’s protection against HPV infection.
Respondents’ fears were also linked to mistrust of
pharmaceutical companies, perceived as profit-making
entities that wanted to sell their products, even at the
cost of others’ well-being (st.29,+3). Participating
mothers stated, “Ah yes, surely they make plenty of
money with it. Without really telling the truth about
the severe side effects” and “This is nothing new. The
pharmaceutical companies often are big crooks with
dollar signs in their eyes. The humane element in the
pharmaceutical industry has gone, regrettably.” This
mistrust of the pharmaceutical industry and the prevail-
ing fear about potential negative consequences made
respondents perceive children vaccinated against HPV
as test objects; one mother said, “I don’t really want my
daughter to act as a guinea pig or for people to make
money out of her at the cost of her health.” Thus, these
participants considered it better to be safe and not get
vaccinated, than to regret vaccination due to potential
future side effects (st.12,+3). However, they also
expressed that only the future could tell whether they
had made the right decision.
This perspective also involved a lack of trust in the
government to give advice about HPV vaccination
(st.28,0). One interviewee referred to the government’s
hasty choice to include the HPV vaccine in the NIP.
In addition, these respondents placed little value on
the role of GPs relative to those with other perspec-
tives (st.2,0).
Participants with this perspective perceived that ad-
equate and objective information on HPV vaccination
was difficult to find (st.3,0; st.4,+2), which may partly
explain the perception that they were inadequately in-
formed about HPV and related diseases (st.5,-1). In
addition, they perceived HPV as a complex topic and
thus felt that parents should make vaccination deci-
sions (st.24,+3). One respondent emphasized that her
daughter was very compliant, with a constantly altering
opinion depending on with whom she had spoken.
Perspective 3: “Lack of information and awareness”
The defining feature of this perspective, with which 38
participants [14 (37%) parents, 14 (37%) girls, 10 (26%)
boys] were associated significantly, was lack of awareness
and information about HPV and HPV-related disease,
which posed a major barrier to informed decision making
(st.25,-4; st.6,-4). Many participants stated that the topic
of HPV was completely unclear for them, and some had
not heard about HPV before this study. Interviewees
linked HPV with cervical cancer, albeit diffusely. Given
their limited awareness and information, they pondered
the advantages and disadvantages of vaccination, being
unclear about its potential side effects (st.27,+4) while per-
ceiving the benefits of vaccination in general, and HPV
vaccination specifically, as important (st.9,+4; st.21,+3).
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This perspective involved the least perceived severity
among viewpoints of the potential consequences of
HPV-related disease (st.18,0) and a neutral perception of
susceptibility (st.14,0; st.13,+1). Yet, interviewees stated
that cervical cancer could be severe. This contradictory
view could be explained by the expressed lack of infor-
mation, awareness, and clarity regarding the link be-
tween HPV and (cervical) cancer.
Respondents valued friends’ and family members’ opin-
ions about the HPV vaccine (st.33,+1), and thus appeared
to be influenced more easily by the social environment. In
contrast to participants with other perspectives, those with
this viewpoint valued GPs’ advice highly (st.2,+3). A 14-
year-old girl said, “I think advice from the GP is important
because you don’t know the drawbacks of an HPV shot.
There is not enough information about the HPV shot”
and a father stated, “Explanation by a GP gives you some
more certainty! He is a specialist after all.”
Interviewees wished that they knew more about HPV
and HPV-related disease. When asked how information
should be distributed, one respondent suggested more
active communication about the vaccine through spot
advertisements and increasing awareness through GPs
and informational pamphlets distributed with formal in-
vitations for other vaccinations.
In addition, many children holding this view appeared
to trust and rely on their parents’ decision, but felt that
they should have a say in this decision despite their lim-
ited knowledge about the HPV vaccine. A 13-year-old
girl, who had declined vaccination, stated that she would
have liked to know more about HPV before making a
decision and expressed anticipated regret if she were to
acquire an HPV-related disease later in life. However,
she declined having plans to rethink her decision.
Perspective 4: “My body, my choice”
The 22 participants [2 (9%) parents, 15 (68%) girls, 5
(23%) boys], in large majority girls, associated significantly
with this perspective did not perceive HPV-related dis-
eases as a particular threat to health. Perceived susceptibil-
ity was especially low, as respondents did not seem to
worry about exposure to HPV and related diseases com-
pared with those with other perspectives (st.13,−2). One
14-year-old girl stated that she had decided to decline the
HPV vaccine, but not other childhood vaccinations: “…
these I felt were important and therefore I accepted them.”
This viewpoint was further justified by the fact that com-
mon childhood vaccinations prevent diseases perceived as
more common than HPV-related disease.
Yet, respondents felt clearly that making the decision to
vaccinate before becoming sexually active was important
(st.16,-3). Although they believed that vaccination in gen-
eral benefitted oneself and others (st.21,+2), respondents
representing this perspective seemed to be undecided
about whether HPV vaccination has more disadvantages
than advantages (st.20,0). One interviewee referred to
unknown side effects, and another referred to the effect-
iveness of the vaccine, stating she had heard that the
vaccine’s ability to protect against cervical cancer was
uncertain.
The most important aspect of this viewpoint was con-
trol over the decision of whether to vaccinate. Children
believed that they should make this decision (st.31,+4),
positioning themselves (as vaccine recipients) centrally
in responses to open-ended questions and in ex-post in-
terviews; a 15-year-old girl stated, “It’s your body so I
think you may take the decision yourself.” Children also
expressed that their opinions were equally important as
their parents’, if not more important: 14- and 13-year-old
girls stated, “Well, they thought my opinion was really
important; so I didn’t have to get it if I didn’t want it”
and “Yes, [my parents] thought my opinion was more
important.”
However, children also valued their parents’ know-
ledge and saw the decision as joint (st.30,+4): 12- and
14-year-old girls said, “But it may be that as a child you
are not too sure about what it involves, so therefore I
find it important that parents also have a say in this”
and “As a child you don’t know much about this but
your parents just a bit more, so it’s useful to have them
help decide.”
A probable cause for this rather contradictory view on
who should make the decision is that children want to
be able to decide who can influence the decision: prefer-
ably only people from their “circle of trust” (st.33,-3).
Yet, those with this perspective greatly appreciated GPs’
recommendations (st.2,+3); a 13-year-old girl said of her
GP, “He knows me,” and referred to GPs’ medical know-
ledge about their clients. Yet, neither girl with this per-
spective who was interviewed had actively reached out
to her GP for advice, despite having decided to decline
the vaccination. Expert advice from other sources, such
as the government, was not considered to be relevant
(st.28,-2). However, most children did not appear to fully
understand the term “government” or what it entailed.
Lack of information did not appear to be a barrier for
respondents with this perspective (st.25,+3), even those
who expressed that they knew little about HPV and HPV-
related disease. Compared with participants with other
perspectives, they felt that knowledge, when needed, was
easily obtainable from parents or GPs (st.3,+2).
Discussion
Although many studies have explored beliefs regarding
the HPV vaccine, this study is the first to investigate
jointly the prevailing perspectives of girls, boys, and par-
ents, and to identify determinants underlying HPV vaccin-
ation decisions. The results revealed four perspectives:
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“prevention is better than cure,” “fear of unknown side
effects,” “lack of information and awareness,” and “my
body, my choice.”
Our results suggest that the first two perspectives were
coherent and very distinct. Those with perspective 1
favoured vaccination, as it is not only promoted by a
trusted source (the government), but is also an effective
means of preventing HPV-related disease, thereby minim-
izing perceived susceptibility and severity. These determi-
nants coincide strongly with previous findings about HPV
vaccine uptake [9, 27, 33]. In contrast, those with perspec-
tive 2 did not view HPV as a particular threat to health
and were critical of the roles of the government and the
pharmaceutical industry in HPV vaccination. Their inclin-
ation to not vaccinate was dominated by fear of potential
long-term side effects, in accordance with findings about
HPV vaccination refusal [9, 10, 14, 15]. In relation to the
HBM, those with perspective 1 are highly likely to accept
HPV vaccination, as the perceived threat is seen as consid-
erable, perceived benefits outweigh barriers, and self-
efficacy is present. Furthermore, some cues to action can
also be seen as additional “triggers” positively influencing
uptake. On the other hand, those with perspective 2 are
unlikely to accept HPV vaccination, as the perceived
threat is minimal and the perceived barriers clearly out-
weigh any benefit. Furthermore, cues to action indicate a
need for more objective and adequate information. How-
ever, it is unclear what information would be adequate
and by whom – other than government or the pharma-
ceutical industry – it should be provided to satisfy them.
In both of these perspectives, the vaccination decision
seems to be well considered and clear.
In contrast, the determinants underlying perspectives 3
and 4 appear to be ambiguous and, to some extent, inco-
herent. Those with perspective 3 clearly showed a lack of
awareness and information needed to make informed de-
cisions about HPV vaccination. This perspective appears
to involve doubt about vaccination, as contracting HPV
infection or HPV-related disease was not perceived as a
particular threat, and neither benefits nor barriers clearly
carried more weight. Previous studies have shown that
knowledge has different effects on vaccination decisions.
Lack of knowledge or information can be a reason to de-
cline vaccination [18], but it is not necessarily a factor in
vaccination rejection [14, 26]. Those with this perspective
appeared to be more easily influenced by their surround-
ings, valuing the opinions of others and their GP; children
tended to rely on their parents’ vaccination decision. In
contrast, and despite potential influences from social sur-
roundings, those with perspective 4 wanted children, who
ultimately experience the consequences, to actively con-
trol final vaccination decisions. These respondents also
felt that they possessed sufficient information to make
vaccination decisions, although study data suggest that
they knew very little about HPV (see discussion para-
graph 6 and 7).
In relation to the HBM, the vaccination decision in
perspective 3 can be interpreted as being in a modifiable
phase, given the clear lack of vaccination preference and
prevailing emotions regarding the topic. Those with this
perspective are not likely to vaccinate against HPV, as
they feel no sense of urgency in terms of perceived
threat or benefit. Contrary to those with the first two
perspectives, the deliberations of those with perspective
3 appear, at best, to be characterized by doubt. Those
with perspective 4 (largely children) are arguably also in
a modifiable phase, with minimal awareness and per-
ceived severity and susceptibility of HPV and HPV-
related disease, and no clear idea of HPV immunization
benefits and barriers. The combined lack of awareness
and focus on children’s roles in vaccination decision sug-
gest that these individuals are overconfident in children’s
ability and willingness to acquire and weigh the required
information to make well-considered decisions about
HPV vaccination.
Interestingly, and significant for the future uptake of
this new generation of vaccines of which HPV is con-
sidered to be the first, the importance of individual
deliberation and choice in immunization programs and
vaccination policies is increasing [39]. In many coun-
tries, including the Netherlands, childhood vaccination
is portrayed as “the natural thing to do” and considered
to be part of “responsible parenting” [40]. As the study
results indicate, attitudes about HPV vaccination devi-
ate from this institutionalized “immunization logic”;
this vaccination is seen as a choice for which potential
users bear private responsibility. This situation poses a
new policy challenge for governments and public health
authorities to inform and potentially “persuade” target
groups to participate in vaccination programs, thereby
rendering them effective. Individuals facing the choice
of whether to vaccinate against HPV need tailor-made
information, which must address subgroups with di-
verse beliefs and health orientations. Furthermore, this
new perception of choice may spill over to other
vaccinations included in the NIP, potentially leading to
(re)emphasis of their possible side effects and dangers.
This was the case in the 1990s, when measles, mumps,
and rubella vaccination was said to cause autism, lead-
ing to a decline in its uptake [41, 42]. This shifting vac-
cination logic requires the rethinking of immunization
policies [39].
Although the participants in this study were sampled
purposively, exploring associations between perspectives
and background characteristics may generate interesting
ideas for further research. Firstly, most parents held per-
spectives 1 and 2. Most children held perspectives 3 and
4, or were not associated with any perspective, possibly
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indicating lack of clear perspective about this topic. Sec-
ondly, perspectives were not associated with parents’
gender, but more girls were associated with perspective
4 and more boys with perspective 1. Thirdly, perspec-
tives were not associated with parents’ education level,
but children with lower education more often associ-
ated with perspectives 1, 4, or had no clear perspective.
Fourthly, participants with perspectives 1 and 2 scored
higher on personality trait conscientiousness, while
those with perspective 4 scored lower; other Big Five In-
ventory [43] personality traits showed no associations.
The questionnaire also included questions about HPV
vaccination. Firstly, parents who had received the formal
invitation letter for their child’s vaccination more often
held perspectives 2 and 4, whereas more of those who had
not yet received this letter associated with perspectives 1
and 3, or no perspective. Secondly, those with perspective
2 more often had actively searched for information about
HPV vaccination, and those with perspective 3 or no clear
perspective less often. Thirdly, those with perspective 2
scored higher on a knowledge of HPV scale, adapted from
Gefenaite et al. [15]. This coincides with earlier findings
that those critical of new technologies are often also highly
informed [44]. Finally, more parents who had discussed
about the HPV vaccine with others held perspective 2,
whereas more children who had talked about the HPV
vaccine with others held perspective 4.
The findings of this study are important for several
reasons. First, the modifiable-phase status of those with
perspectives 3 and 4, who have not (yet) made well-
considered decisions about HPV immunization, empha-
sizes the need for investment in tailor-made independent
communication policies (e.g., spot advertisements, infor-
mational pamphlets accompanying invitations to preced-
ing vaccine sessions, promotion of contact with GP or
other medical professionals for advice) to enhance HPV
immunization. A focus on increasing awareness and
knowledge is particularly important among those with
perspectives 3 and 4, who appeared to be rather unfamiliar
with the topic of HPV. The involvement of adolescents in
decision-making is a particularly important opportunity to
provide HPV education. HPV awareness could be in-
creased by incorporating informational sessions in schools’
sexual health education classes. When providing informa-
tion to those with perspectives 3 and 4, a focus on solidify-
ing the link between HPV and cervical cancer, and
emphasis that cervical cancer is only one of many severe
consequences of persistent HPV, would be beneficial. Sec-
ond, as suggested by Griffioen et al. [25], there appears to
be a missed opportunity in educating children of parents
with perspective 1, who make HPV vaccination decisions
for their child without discussion given the perceived
complexity of the topic. Parents should be encouraged to
have open dialogs with their children, which clearly differs
from perspective 4. However, HPV vaccination decision
making may become tense when parents and children
hold different perspectives.
This study has some limitations. First, as the aim of a
Q-methodological study is to describe prevailing perspec-
tives, the current data do not indicate how common these
perspectives are in society; such information, acquired
with a survey approach [45], could be valuable for asses-
sing whether and how vaccination rates can be further
improved. The same applies to relations between respon-
dents’ perspectives and background characteristics. The
associations discussed above are tentative and, although
some have clear face validity, should be seen primarily as
hypotheses for further research. One of the reasons under-
lying the different perspectives among girls and boys may
be that HPV vaccination is part of the NIP only for girls in
the Netherlands; thus, boys and their parents do not re-
ceive a formal invitation letter, which may influence their
deliberation, awareness and perspective on HPV vaccin-
ation. Second, a non-systematic literature review was con-
ducted to develop the set of statement, which does not
guarantee elimination of bias. The process, however, of
developing the statement set involved two researchers in-
dependently identifying a large variety of motives and be-
liefs potentially influencing decisions to vaccinate against
HPV, twice the input from two experts, and a pilot among
children and parents to ensure that nothing had been
omitted. Third, although much emphasis was placed on
the development of a statement set that would be suitable
for parents and children, some adjustments had to be
made after the pilot study to fit children’s linguistic abil-
ities and varying levels of HPV awareness. During the
main study, no further concerns arose about the compre-
hensibility and completeness of the statements except that
the term “government” needed clarification for some chil-
dren. Finally, statement categorization within the HBM
was challenging, especially as the relationships among
HBM components are not clearly defined [34] and clear
construct definitions are lacking, particularly for the cues
to action component [31]. Therefore, some statements
could have been classified differently; in particular, some
of those categorized as social influence could also have
been classified as cues to action. However, we believe that
the HBM functioned as a comprehensive framework for
developing the statement set, as confirmed by the fact that
no main study participant reported missing an aspect im-
portant to their perspective.
Conclusions
Our study identified four prevailing perspectives on
HPV vaccination among girls, boys and parents. Given
the aim of publically funded vaccination programs to
minimize the spread of HPV infection and HPV-related
disease and concerns about current uptake, knowledge
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of existing perspectives on HPV vaccination in the pub-
lic is crucial for policies wishing to promote uptake.
HPV vaccine clearly deviates from other childhood
vaccinations in NIP’s, as vaccinating against HPV is not
necessarily considered “the natural thing to do”. Increas-
ing awareness and knowledge by investing in tailored-
made communication policies could help promote the
uptake among those not familiar with the vaccine. This
is especially important among those holding perspective
3 or 4, who appeared to be in a modifiable phase. Des-
pite the non-generalizability of this study, the methods
and results of this study could contribute to the develop-
ment of campaigns wishing to address uptake of HPV
vaccination.
Appendix 1
We conduct this study because we are curious to know
what children and parents think about HPV vaccination.
HPV stands for human papillomavirus. There are differ-
ent variants of this virus, with different effects on your
health. HPV infection can occur in two ways: through
skin-to-skin contact or via sexual contact. The variants
of HPV that can lead to severe diseases are transmitted
through sexual contact.
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HBM: Health belief model; HPV: Human papillomavirus; NIP: National
immunization program
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